[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU3221793A - Factor x-derived polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting inflammation - Google Patents

Factor x-derived polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting inflammation

Info

Publication number
AU3221793A
AU3221793A AU32217/93A AU3221793A AU3221793A AU 3221793 A AU3221793 A AU 3221793A AU 32217/93 A AU32217/93 A AU 32217/93A AU 3221793 A AU3221793 A AU 3221793A AU 3221793 A AU3221793 A AU 3221793A
Authority
AU
Australia
Prior art keywords
factor
systems
therapeutic methods
peptide antibodies
derived polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32217/93A
Inventor
Dario C Altieri
Thomas S. Edgington
Daryl S Fair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU3221793A publication Critical patent/AU3221793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU32217/93A 1991-11-22 1992-11-20 Factor x-derived polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting inflammation Abandoned AU3221793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79822191A 1991-11-22 1991-11-22
US798221 1991-11-22

Publications (1)

Publication Number Publication Date
AU3221793A true AU3221793A (en) 1993-06-15

Family

ID=25172837

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32217/93A Abandoned AU3221793A (en) 1991-11-22 1992-11-20 Factor x-derived polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting inflammation

Country Status (2)

Country Link
AU (1) AU3221793A (en)
WO (1) WO1993009803A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877289A (en) * 1992-03-05 1999-03-02 The Scripps Research Institute Tissue factor compositions and ligands for the specific coagulation of vasculature
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
US6036955A (en) * 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
US6004555A (en) * 1992-03-05 1999-12-21 Board Of Regents, The University Of Texas System Methods for the specific coagulation of vasculature
US6093399A (en) * 1992-03-05 2000-07-25 Board Of Regents, The University Of Texas System Methods and compositions for the specific coagulation of vasculature
EP0738156A1 (en) * 1993-12-27 1996-10-23 Hamilton Civic Hospitals Research Development, Inc. Methods and compositions for inhibiting thrombogenesis
HU223006B1 (en) * 1994-10-25 2004-03-01 Glaxo Group Ltd. Binding agents to cd23
ES2702365T3 (en) * 2008-06-19 2019-02-28 Prothix Bv Use of anti-factor XI antibodies for the prevention or treatment of thrombus formation

Also Published As

Publication number Publication date
WO1993009803A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
EP0605442A4 (en) Recombinant antibodies for human therapy.
AU7170591A (en) Particulate delivery system
AU4841093A (en) Artificial disk system
AU3050892A (en) Delivery system
AU1317992A (en) Delivery system for enhanced onset and increased potency
AU4624089A (en) Transportation dispatch and delivery tracking system
AU1164592A (en) Radiotelephony system
AU3851889A (en) Topical delivery system
AU5671594A (en) Human tissue factor related dna segments, polypeptides and antibodies
AU3690393A (en) Concentric fuel line system
AU3221793A (en) Factor x-derived polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting inflammation
AU4514093A (en) Recombinant antibody against human interleukin-1
AU1770492A (en) Microassay system and neutrophil derived secretagogue
AU2238192A (en) Modified peptides transportable into the central nervous system
AU4773293A (en) Multiple particulate antigen delivery system
AU7880291A (en) Tracking system
AU4480189A (en) Diverter valve
AU4889393A (en) Human monoclonal anti-peptide antibody and DNA encoding thereof
AU1314492A (en) Chimaeric polypeptides
AU7504691A (en) Monoclonal antibodies against pp4, processes for the preapration thereof and the use thereof
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
AU3647089A (en) Bump avoid system
LTIP606A (en) Peptide compounds, method for the preparation and use thereof
AU3088689A (en) Local area system transport
LTIP608A (en) Peptide compounds, method for the preparation and use thereof